M. D. Holida Et Al. , "Once every 4 weeks-2 mg/kg of pegunigalsidase alfa for treating Fabry disease Preliminary results of a phase 3 study," 15th Annual Research Meeting of the WORLDSymposium(TM) , vol.126, Florida, United States Of America, 2019
Holida, M. D. Et Al. 2019. Once every 4 weeks-2 mg/kg of pegunigalsidase alfa for treating Fabry disease Preliminary results of a phase 3 study. 15th Annual Research Meeting of the WORLDSymposium(TM) , (Florida, United States Of America).
Holida, M. D., Bernat, J., Longo, N., Goker-Alpan, O., Wallace, E., Schiffmann, R., ... Deegan, P.(2019). Once every 4 weeks-2 mg/kg of pegunigalsidase alfa for treating Fabry disease Preliminary results of a phase 3 study . 15th Annual Research Meeting of the WORLDSymposium(TM), Florida, United States Of America
Holida, Myrl Et Al. "Once every 4 weeks-2 mg/kg of pegunigalsidase alfa for treating Fabry disease Preliminary results of a phase 3 study," 15th Annual Research Meeting of the WORLDSymposium(TM), Florida, United States Of America, 2019
Holida, Myrl D. Et Al. "Once every 4 weeks-2 mg/kg of pegunigalsidase alfa for treating Fabry disease Preliminary results of a phase 3 study." 15th Annual Research Meeting of the WORLDSymposium(TM) , Florida, United States Of America, 2019
Holida, M. D. Et Al. (2019) . "Once every 4 weeks-2 mg/kg of pegunigalsidase alfa for treating Fabry disease Preliminary results of a phase 3 study." 15th Annual Research Meeting of the WORLDSymposium(TM) , Florida, United States Of America.
@conferencepaper{conferencepaper, author={Myrl D. Holida Et Al. }, title={Once every 4 weeks-2 mg/kg of pegunigalsidase alfa for treating Fabry disease Preliminary results of a phase 3 study}, congress name={15th Annual Research Meeting of the WORLDSymposium(TM)}, city={Florida}, country={United States Of America}, year={2019}}